Colonization with third-generation cephalosporin-resistant Enterobacteriaceae on hospital admission: prevalence and risk factors

Standard

Colonization with third-generation cephalosporin-resistant Enterobacteriaceae on hospital admission: prevalence and risk factors. / Hamprecht, A; Rohde, A M; Behnke, M; Feihl, S; Gastmeier, P; Gebhardt, F; Kern, W V; Knobloch, J K.-M.; Mischnik, A; Obermann, B; Querbach, C; Peter, S; Schneider, C; Schröder, W; Schwab, F; Tacconelli, E; Wiese-Posselt, M; Wille, T; Willmann, M; Seifert, H; Zweigner, J; DZIF-ATHOS Study Group .

in: J ANTIMICROB CHEMOTH, Jahrgang 71, Nr. 10, 10.2016, S. 2957-63.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Hamprecht, A, Rohde, AM, Behnke, M, Feihl, S, Gastmeier, P, Gebhardt, F, Kern, WV, Knobloch, JK-M, Mischnik, A, Obermann, B, Querbach, C, Peter, S, Schneider, C, Schröder, W, Schwab, F, Tacconelli, E, Wiese-Posselt, M, Wille, T, Willmann, M, Seifert, H, Zweigner, J & DZIF-ATHOS Study Group 2016, 'Colonization with third-generation cephalosporin-resistant Enterobacteriaceae on hospital admission: prevalence and risk factors', J ANTIMICROB CHEMOTH, Jg. 71, Nr. 10, S. 2957-63. https://doi.org/10.1093/jac/dkw216

APA

Hamprecht, A., Rohde, A. M., Behnke, M., Feihl, S., Gastmeier, P., Gebhardt, F., Kern, W. V., Knobloch, J. K-M., Mischnik, A., Obermann, B., Querbach, C., Peter, S., Schneider, C., Schröder, W., Schwab, F., Tacconelli, E., Wiese-Posselt, M., Wille, T., Willmann, M., ... DZIF-ATHOS Study Group (2016). Colonization with third-generation cephalosporin-resistant Enterobacteriaceae on hospital admission: prevalence and risk factors. J ANTIMICROB CHEMOTH, 71(10), 2957-63. https://doi.org/10.1093/jac/dkw216

Vancouver

Bibtex

@article{942728b5eb47428081472bb6d5c6db25,
title = "Colonization with third-generation cephalosporin-resistant Enterobacteriaceae on hospital admission: prevalence and risk factors",
abstract = "OBJECTIVES: The objectives of this study were to prospectively assess the rectal carriage rate of third-generation cephalosporin-resistant Enterobacteriaceae (3GCREB) in non-ICU patients on hospital admission and to investigate resistance mechanisms and risk factors for carriage.METHODS: Adult patients were screened for 3GCREB carriage at six German tertiary care hospitals in 2014 using rectal swabs or stool samples. 3GCREB isolates were characterized by phenotypic and molecular methods. Each patient answered a questionnaire about potential risk factors for colonization with MDR organisms (MDROs). Univariable and multivariable risk factor analyses were performed to identify factors associated with 3GCREB carriage.RESULTS: Of 4376 patients, 416 (9.5%) were 3GCREB carriers. Escherichia coli was the predominant species (79.1%). ESBLs of the CTX-M-1 group (67.3%) and the CTX-M-9 group (16.8%) were the most frequent β-lactamases. Five patients (0.11%) were colonized with carbapenemase-producing Enterobacteriaceae. The following risk factors were significantly associated with 3GCREB colonization in the multivariable analysis (P < 0.05): centre; previous MDRO colonization (OR = 2.12); antibiotic use within the previous 6 months (OR = 2.09); travel outside Europe (OR = 2.24); stay in a long-term care facility (OR = 1.33); and treatment of gastroesophageal reflux disease (GERD) (OR = 1.22).CONCLUSIONS: To our knowledge, this is the largest admission prevalence study of 3GCREB in Europe. The observed prevalence of 9.5% 3GCREB carriage was higher than previously reported and differed significantly among centres. In addition to previously identified risk factors, the treatment of GERD proved to be an independent risk factor for 3GCREB colonization.",
keywords = "Journal Article",
author = "A Hamprecht and Rohde, {A M} and M Behnke and S Feihl and P Gastmeier and F Gebhardt and Kern, {W V} and Knobloch, {J K.-M.} and A Mischnik and B Obermann and C Querbach and S Peter and C Schneider and W Schr{\"o}der and F Schwab and E Tacconelli and M Wiese-Posselt and T Wille and M Willmann and H Seifert and J Zweigner and {DZIF-ATHOS Study Group}",
note = "{\textcopyright} The Author 2016. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.",
year = "2016",
month = oct,
doi = "10.1093/jac/dkw216",
language = "English",
volume = "71",
pages = "2957--63",
journal = "J ANTIMICROB CHEMOTH",
issn = "0305-7453",
publisher = "Oxford University Press",
number = "10",

}

RIS

TY - JOUR

T1 - Colonization with third-generation cephalosporin-resistant Enterobacteriaceae on hospital admission: prevalence and risk factors

AU - Hamprecht, A

AU - Rohde, A M

AU - Behnke, M

AU - Feihl, S

AU - Gastmeier, P

AU - Gebhardt, F

AU - Kern, W V

AU - Knobloch, J K.-M.

AU - Mischnik, A

AU - Obermann, B

AU - Querbach, C

AU - Peter, S

AU - Schneider, C

AU - Schröder, W

AU - Schwab, F

AU - Tacconelli, E

AU - Wiese-Posselt, M

AU - Wille, T

AU - Willmann, M

AU - Seifert, H

AU - Zweigner, J

AU - DZIF-ATHOS Study Group

N1 - © The Author 2016. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

PY - 2016/10

Y1 - 2016/10

N2 - OBJECTIVES: The objectives of this study were to prospectively assess the rectal carriage rate of third-generation cephalosporin-resistant Enterobacteriaceae (3GCREB) in non-ICU patients on hospital admission and to investigate resistance mechanisms and risk factors for carriage.METHODS: Adult patients were screened for 3GCREB carriage at six German tertiary care hospitals in 2014 using rectal swabs or stool samples. 3GCREB isolates were characterized by phenotypic and molecular methods. Each patient answered a questionnaire about potential risk factors for colonization with MDR organisms (MDROs). Univariable and multivariable risk factor analyses were performed to identify factors associated with 3GCREB carriage.RESULTS: Of 4376 patients, 416 (9.5%) were 3GCREB carriers. Escherichia coli was the predominant species (79.1%). ESBLs of the CTX-M-1 group (67.3%) and the CTX-M-9 group (16.8%) were the most frequent β-lactamases. Five patients (0.11%) were colonized with carbapenemase-producing Enterobacteriaceae. The following risk factors were significantly associated with 3GCREB colonization in the multivariable analysis (P < 0.05): centre; previous MDRO colonization (OR = 2.12); antibiotic use within the previous 6 months (OR = 2.09); travel outside Europe (OR = 2.24); stay in a long-term care facility (OR = 1.33); and treatment of gastroesophageal reflux disease (GERD) (OR = 1.22).CONCLUSIONS: To our knowledge, this is the largest admission prevalence study of 3GCREB in Europe. The observed prevalence of 9.5% 3GCREB carriage was higher than previously reported and differed significantly among centres. In addition to previously identified risk factors, the treatment of GERD proved to be an independent risk factor for 3GCREB colonization.

AB - OBJECTIVES: The objectives of this study were to prospectively assess the rectal carriage rate of third-generation cephalosporin-resistant Enterobacteriaceae (3GCREB) in non-ICU patients on hospital admission and to investigate resistance mechanisms and risk factors for carriage.METHODS: Adult patients were screened for 3GCREB carriage at six German tertiary care hospitals in 2014 using rectal swabs or stool samples. 3GCREB isolates were characterized by phenotypic and molecular methods. Each patient answered a questionnaire about potential risk factors for colonization with MDR organisms (MDROs). Univariable and multivariable risk factor analyses were performed to identify factors associated with 3GCREB carriage.RESULTS: Of 4376 patients, 416 (9.5%) were 3GCREB carriers. Escherichia coli was the predominant species (79.1%). ESBLs of the CTX-M-1 group (67.3%) and the CTX-M-9 group (16.8%) were the most frequent β-lactamases. Five patients (0.11%) were colonized with carbapenemase-producing Enterobacteriaceae. The following risk factors were significantly associated with 3GCREB colonization in the multivariable analysis (P < 0.05): centre; previous MDRO colonization (OR = 2.12); antibiotic use within the previous 6 months (OR = 2.09); travel outside Europe (OR = 2.24); stay in a long-term care facility (OR = 1.33); and treatment of gastroesophageal reflux disease (GERD) (OR = 1.22).CONCLUSIONS: To our knowledge, this is the largest admission prevalence study of 3GCREB in Europe. The observed prevalence of 9.5% 3GCREB carriage was higher than previously reported and differed significantly among centres. In addition to previously identified risk factors, the treatment of GERD proved to be an independent risk factor for 3GCREB colonization.

KW - Journal Article

U2 - 10.1093/jac/dkw216

DO - 10.1093/jac/dkw216

M3 - SCORING: Journal article

C2 - 27317445

VL - 71

SP - 2957

EP - 2963

JO - J ANTIMICROB CHEMOTH

JF - J ANTIMICROB CHEMOTH

SN - 0305-7453

IS - 10

ER -